Skip to content
March 25, 2026
  • 60 Batches, Including Paracetamol and Cefixime, Fail CDSCO Quality Checks
  • Government Bans Entry of Pharma Representatives in Public Hospitals
  • India Launches Global Study to Integrate Ayurveda with Modern TB Treatment
  • Pacific OneHealth to Invest ₹300 Cr in Micro-Hospitals to Decentralise Care in North India
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • Central Drugs Laboratory

Central Drugs Laboratory

Indian Industries Association 34
  • News

Government Snake Venom Antiserum Sample Fails Quality Test at CDL Kasauli

tishha_newsJanuary 21, 2026January 21, 202604 mins

A sample of Snake Venom Antiserum (SVA), used for treating snakebite cases, has failed quality testing at the Central Drugs…

Read More
image 10
  • News

Abhayrab Remains Safe When Sourced Through Authorised Channels, Says Indian Immunologicals

tishha_newsJanuary 10, 2026January 10, 202607 mins

Amid international advisories urging caution for travellers vaccinated against rabies in India due to reports of counterfeit vaccines, Indian Immunologicals…

Read More

Most Viewed

News
60 Batches, Including Paracetamol and Cefixime, Fail CDSCO Quality Checks
In a recent drug safety update, 60 batches of medicines…
News
Government Bans Entry of Pharma Representatives in Public Hospitals
In a significant move aimed at strengthening ethical medical practices,…

Random

1

60 Batches, Including Paracetamol and Cefixime, Fail CDSCO Quality Checks

  • News
2

Government Bans Entry of Pharma Representatives in Public Hospitals

  • News
3

India Launches Global Study to Integrate Ayurveda with Modern TB Treatment

  • News
4

Pacific OneHealth to Invest ₹300 Cr in Micro-Hospitals to Decentralise Care in North India

  • News
5

Harish Rana, First Indian Granted Passive Euthanasia by Supreme Court, Passes Away After 13-year Ordeal

  • News
6

Temasek-Backed Manipal Health files for IPO Amid Healthcare Demand Surge

  • News
7

QCIL Partners with Intuitive to Expand Robotic Surgery in Tier 2 & 3 Cities

  • News
8

Dr Reddy’s Launches Low-Cost Semaglutide Generic ‘Obeda’ in India’s Booming GLP-1 Market

  • News
tishha_logo
TISHHA News Developed By BlazeThemes.